Showing results (301-310 of 345) with videos related to
Sort By:
Pageof 35
International Journal of Biological Macromolecules|May 17, 2025
Bacteria-responsive antimicrobial and hemostatic cellulose-based dressing for wound treatmentsYuhan Mai, Yang Zhou, Qihuang Ye, et al.Frontiers in Pharmacology|November 17, 2022
Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal inflammatory, and barrier function by activating the farnesoid X receptorKaijia Tang, Danli Kong, Yuan Peng, et al.Chemical Science|June 24, 2021
All-in-one mitochondria-targeted NIR-II fluorophores for cancer therapy and imagingYujia Zheng, Qianqian Li, Jing Wu, et al.Journal of Bacteriology|June 29, 2012
Genome sequences of three species in the family PlanctomycetaceaeMin Guo, Xifang Han, Tao Jin, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 14, 2008
Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female ratsEric G Vajda, Aimee Hogue, Kimberly N Griffiths, et al.Frontiers in Oncology|November 4, 2021
ARV-825 Demonstrates Antitumor Activity in Gastric Cancer via MYC-Targets and G2M-Checkpoint Signaling PathwaysXinmei Liao, Xiaoqing Qian, Zimu Zhang, et al.Carcinogenesis|February 1, 2024
The BET inhibitor GNE-987 effectively induces anti-cancer effects in T-cell acute lymphoblastic leukemia by targeting enhancer regulated genesJuanjuan Yu, Yang Yang, Rongfang Zhou, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 2, 2025
Safety and immunogenicity of hepatitis E vaccine in compensated liver cirrhosis with chronic hepatitis BXuejiao Liao, Dapeng Li, Yingying Su, et al.Surgery|October 24, 2022
Impact of sarcopenia on the surgical outcomes in patients with hepatolithiasis: A multicenter 10-year experienceTingting Wang, Xinlei Chen, Chengyu Liao, et al.Biochemical and Biophysical Research Communications|March 17, 2022
BRD4 inhibitor MZ1 exerts anti-cancer effects by targeting MYCN and MAPK signaling in neuroblastomaXianbing Zhang, Xinyi Guo, Ran Zhuo, et al.Pageof 35